SCHEMBL4790305

SCHEMBL4790305

CS(=O)(=O)c1ccc2c(c1)CCN(C(=O)C1CCCCC1(C(N)=O)C1(C#N)CC1)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 1/20 0.41
▸ CTSK P43235 5/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.37
▸ CTSB P07858 3/20 0.36
▸ CTSS P25774 2/20 0.36
▸ CTSL P07711 2/20 0.36
▸ CPT2 P23786 1/20 0.36
▸ CPT1A P50416 1/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ KMT2A Q03164 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA7 P43166 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4789901 0.88 HDAC6 (0.38) CTSKHDAC6CTSBCTSSCTSL
SCHEMBL4789865 0.84 KEAP1 (0.51) CTSKCTSBCTSSCTSLCPT2
SCHEMBL4788689 0.82 PDE4B (0.46) KMT2AMAPT
SCHEMBL4573200 0.80 CTSK (0.57) CTSKCTSBCTSSCTSLCYP3A4
SCHEMBL4573939 0.79 SLC6A9 (0.48) CTSKCTSBCTSS
SCHEMBL4589748 0.78 CTSB (0.54) CTSKCTSBCTSSCTSLCYP3A4
SCHEMBL4789292 0.76 NAMPT (0.38) CTSKCTSBCTSSCTSLCPT2
SCHEMBL4787927 0.76 CTSK (0.39) CTSKCTSBCTSSCTSLCPT2
SCHEMBL4790306 0.74 CTSK (0.69) CTSKCTSBCTSSCTSLCYP3A4
SCHEMBL4573950 0.71 CTSS (0.45) CTSKCTSBCTSSCTSLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009001128-A1 1,2-CYCL0HEXANE DICARBOXAMIDES AS CATHEPSIN INHIBITORS ASTRAZENECA AB (SE) 2008-12-31 — — WO disclosed
Send feedback